scispace - formally typeset
Open AccessJournal ArticleDOI

Estimates of Incidence and Mortality of Cervical Cancer in 2018: A Worldwide Analysis

Reads0
Chats0
TLDR
The global scale-up of HPV vaccination and HPV-based screening—including self-sampling—has potential to make cervical cancer a rare disease in the decades to come, and could help shape and monitor the initiative to eliminate cervical cancer as a major public health problem.
About
This article is published in The Lancet Global Health.The article was published on 2020-02-01 and is currently open access. It has received 1867 citations till now. The article focuses on the topics: Cervical cancer & HPV infection.

read more

Citations
More filters
Journal ArticleDOI

Cancer incidence, mortality, and burden in China: a time-trend analysis and comparison with the United States and United Kingdom based on the global epidemiological data released in 2020.

TL;DR: Wang et al. as discussed by the authors reviewed the rates and trends of cancer incidence and mortality and disability-adjusted life year (DALY) burden in China, and compared them with those in the United States (US) and the United Kingdom (UK).
Journal ArticleDOI

Planning for tomorrow: global cancer incidence and the role of prevention 2020-2070.

TL;DR: In this article, the authors assess studies modelling the future burden of cancer that underscore how comprehensive cancer prevention strategies can markedly reduce the prevalence of major risk factors and, in so doing, the number of future cancer cases.
Journal ArticleDOI

A Review of Cervical Cancer: Incidence and Disparities.

TL;DR: By addressing racial and ethnic minorities, socioeconomically disenfranchised, and those in rural areas have disparate rates of vaccination, screening and treatment of cervical cancer, leading to worse outcomes, reductions in cervical cancer incidence and mortality may be achieved.
Journal ArticleDOI

NCCN Guidelines Insights: Cervical Cancer, Version 1.2020.

TL;DR: Recent updates to the NCCN guidelines, including changes to first- and second-line systemic therapy recommendations for patients with recurrent or metastatic disease, and emerging evidence on a new histopathologic classification system for HPV-related endocervical adenocarcinoma are focused on.
References
More filters
Journal ArticleDOI

Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries

TL;DR: A status report on the global burden of cancer worldwide using the GLOBOCAN 2018 estimates of cancer incidence and mortality produced by the International Agency for Research on Cancer, with a focus on geographic variability across 20 world regions.
Journal ArticleDOI

Global cancer statistics, 2002.

TL;DR: There are striking variations in the risk of different cancers by geographic area, most of the international variation is due to exposure to known or suspected risk factors related to lifestyle or environment, and provides a clear challenge to prevention.
Book

Cancer Incidence in Five Continents

TL;DR: The aim of this study was to establish a database of histological groups and to provide a level of consistency and quality of data that could be applied in the design of future registries.
Journal ArticleDOI

Human papillomavirus is a necessary cause of invasive cervical cancer worldwide.

TL;DR: The presence of HPV in virtually all cervical cancers implies the highest worldwide attributable fraction so far reported for a specific cause of any major human cancer, and the rationale for HPV testing in addition to, or even instead of, cervical cytology in routine cervical screening.
Journal ArticleDOI

Estimating the global cancer incidence and mortality in 2018: GLOBOCAN sources and methods

TL;DR: The sources and methods used in compiling the cancer statistics in 185 countries are reviewed, and uncertainty intervals are now provided for the estimated sex‐ and site‐specific all‐ages number of new cancer cases and cancer deaths.
Related Papers (5)